Concept paper on the development of a committee for proprietary medicinal products (CPMP) points to consider on stability and traceability requirements for vaccine intermediates(关于专利药物委员会（CPMP）发展的概念文件，考虑疫苗中间体的稳定性和可追溯性要求)